These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21229)

  • 21. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lergotrile and lisuride: in vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptor.
    Kebabian JW; Kebabian PR
    Life Sci; 1978 Nov; 23(22):2199-203. PubMed ID: 31541
    [No Abstract]   [Full Text] [Related]  

  • 23. Alpha-2 adrenergic activity of bromocriptine and quinpirole in chicken pineal gland. Effects on melatonin synthesis and [3H]rauwolscine binding.
    Zawilska J; Iuvone PM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1047-52. PubMed ID: 1979809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
    Weir RL; Hruska RE; Silbergeld EK
    Psychopharmacology (Berl); 1981; 75(2):119-23. PubMed ID: 6798600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Tadepalli AS; Novak PJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):93-105. PubMed ID: 6141774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA
    Biochem Pharmacol; 1982 Aug; 31(16):2643-7. PubMed ID: 6128002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC; Moore KE; Demarest KT
    J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Parkinson's disease with dopamine agonists: a review.
    Lieberman A; Neophytides A; Kupersmith M; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
    Am J Med Sci; 1979; 278(1):65-76. PubMed ID: 39452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorectic effect of lisuride and other ergot derivatives in the rat.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat striatal synaptosomes.
    Rowell PP; Larson BT
    J Anim Sci; 1999 Jul; 77(7):1800-6. PubMed ID: 10438027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action.
    Clemens JA; Smalstig EB; Shaar CJ
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):230-7. PubMed ID: 166535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
    Weiner WJ; Nausieda PA; Klawans HL
    Neurology; 1978 Jul; 28(7):734-7. PubMed ID: 566875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of a long term dihydroergotoxine treatment on agonist and antagonist striatal dopamine binding sites are dose and age related.
    Ferretti C; Blengio M; Eva C; Ghi P; Bosco MC; Portaleone P
    Pharmacol Res Commun; 1986 Oct; 18(10):967-78. PubMed ID: 3809237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    Arnerić SP; Chow SA; Long JP; Fischer LJ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):551-9. PubMed ID: 6142939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain alpha-adrenergic receptors: comparison of [3H]WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex.
    Davis JN; Arnett CD; Hoyler E; Stalvey LP; Daly JW; Skolnick P
    Brain Res; 1978 Dec; 159(1):125-35. PubMed ID: 31963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus properties of clonidine: substitution by ergot derivatives.
    Cunningham KA; Callahan PM; Craigmyle NA; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(3):225-9. PubMed ID: 2868902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.